1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. MEDTRONIC PLC
Medtronic Plc XNYS: MDT
Mid-range Performer
Download real time
92.99 0.09 (0.10%)
Near 52W High of $96.25
4.9M
XNYS Volume

XNYS 08 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Dividend
Medtronic Plc has an upcoming dividend of $0.71 per share due on 26 Sep 2025 See details


Insider Trading disclosures for Medtronic Plc

The latest disclosure was made by Skip Harry Kiil in Medtronic Plc where a trade of 200 Ordinary Shares done at an average price of $91.6 was reported to US exchanges on Sept. 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Skip Harry Kiil EVP & President Cardiovascular Sale of securities on an exchange or to another person at price $ 91.59 per share. 03 Sep 2025 200 35,615 (0%) 0% 91.6 18,318 Ordinary Shares
Skip Harry Kiil EVP & President Cardiovascular Sale of securities on an exchange or to another person at price $ 91.58 per share. 03 Sep 2025 8,405 35,815 (0%) 0% 91.6 769,730 Ordinary Shares
William R. Jellison Director Purchase of securities on an exchange or from another person at price $ 92.37 per share. 22 Aug 2025 2,500 5,000 (0%) 0% 92.4 230,925 Ordinary Shares
William R. Jellison Director Purchase of securities on an exchange or from another person at price $ 92.73 per share. 22 Aug 2025 2,500 2,500 (0%) 0% 92.7 231,825 Ordinary Shares
Michael Marinaro EVP, Pres MedSurg and Americas Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.22 per share. 20 Aug 2025 1,052 51,939 (0%) 0% 93.2 98,067 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 4,458 78,613 (0%) 0% 89.3 398,278 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 2,656 75,957 (0%) 0% 89.3 237,287 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 11,328 0 - - Performance Share Units
Gregory L. Smith EVP Global Ops & Supply Chain Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 11,328 83,071 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 13,054 244,323 (0%) 0% 89.3 1,166,244 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 26,323 257,377 (0%) 0% 89.3 2,351,697 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 40,600 0 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 57,724 283,700 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 57,724 0 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 37,798 247,125 (0%) 0% 89.3 3,376,873 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. 01 Aug 2025 40,600 284,923 (0%) 0% 78 3,166,800 Ordinary Shares
Skip Harry Kiil EVP & President Cardiovascular Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 10,457 51,775 (0%) 0% 0 Ordinary Shares
Skip Harry Kiil EVP & President Cardiovascular Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 10,457 0 - - Performance Share Unit
Skip Harry Kiil EVP & President Cardiovascular Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 2,896 44,220 (0%) 0% 89.3 258,729 Ordinary Shares
Skip Harry Kiil EVP & President Cardiovascular Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 4,659 47,116 (0%) 0% 89.3 416,235 Ordinary Shares
Michael Marinaro EVP, Pres MedSurg and Americas Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 1,741 52,729 (0%) 0% 89.3 155,541 Ordinary Shares
Michael Marinaro EVP, Pres MedSurg and Americas Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 3,158 54,470 (0%) 0% 89.3 282,136 Ordinary Shares
Michael Marinaro EVP, Pres MedSurg and Americas Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 6,535 57,628 (0%) 0% 0 Ordinary Shares
Michael Marinaro EVP, Pres MedSurg and Americas Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 3,126 0 - - Stock Option (Right to Buy)
Michael Marinaro EVP, Pres MedSurg and Americas Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 6,535 0 - - Performance Share Unit
Michael Marinaro EVP, Pres MedSurg and Americas Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 2,864 52,991 (0%) 0% 89.3 255,870 Ordinary Shares
Michael Marinaro EVP, Pres MedSurg and Americas Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. 01 Aug 2025 3,126 55,855 (0%) 0% 78 243,828 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 204 12,410 (0%) 0% 89.3 18,225 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. 01 Aug 2025 22 12,614 (0%) 0% 89.3 1,965 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 58 12,636 (0%) 0% 0 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 93 12,578 (0%) 0% 89.3 8,309 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 246 12,671 (0%) 0% 0 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 214 0 - - Stock Option (Right to Buy)
Denise L. Blomquist Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 58 0 - - Performance Share Unit
Denise L. Blomquist Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 246 0 - - Performance Share Unit
Denise L. Blomquist Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 196 12,428 (0%) 0% 89.3 17,511 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. 01 Aug 2025 214 12,624 (0%) 0% 78 16,692 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 15,249 66,531 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 3,850 54,937 (0%) 0% 89.3 343,959 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 7,744 58,787 (0%) 0% 89.3 691,849 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 15,249 0 - - Performance Share Units
Matthew R. Walter SVP, Chief HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 963 0 - - Stock Option (Right to Buy)
Matthew R. Walter SVP, Chief HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 2,179 0 - - Performance Share Unit
Matthew R. Walter SVP, Chief HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 879 31,857 (0%) 0% 89.3 78,530 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. 01 Aug 2025 963 32,736 (0%) 0% 78 75,114 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 364 31,773 (0%) 0% 89.3 32,520 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. 01 Aug 2025 667 32,137 (0%) 0% 89.3 59,590 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2025 2,179 32,804 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.24 per share. 31 Jul 2025 1,630 71,743 (0%) 0% 90.2 147,091 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 1,278 1,278 - - Stock Option (Right to Buy)
Denise L. Blomquist Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 2,202 2,202 - - Performance Share Units
Denise L. Blomquist Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 2,202 12,425 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 9,786 73,373 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 69,005 69,005 - - Stock Option (Right to Buy)
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 24,465 24,465 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 9,786 51,282 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 69,005 69,005 - - Stock Option (Right to Buy)
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 24,465 24,465 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 37,513 225,976 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 264,518 264,518 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 93,781 93,781 - - Performance Share Units
Skip Harry Kiil EVP & President Cardiovascular Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 7,612 41,318 (0%) 0% 0 Ordinary Shares
Skip Harry Kiil EVP & President Cardiovascular Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 53,671 53,671 - - Stock Option (Right to Buy)
Skip Harry Kiil EVP & President Cardiovascular Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 19,028 19,028 - - Performance Share Units
Michael Marinaro EVP, Pres MedSurg and Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 69,005 69,005 - - Stock Option (Right to Buy)
Michael Marinaro EVP, Pres MedSurg and Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 24,465 24,465 - - Performance Share Units
Michael Marinaro EVP, Pres MedSurg and Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 9,786 51,093 (0%) 0% 0 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 10,874 10,874 - - Performance Share Units
Matthew R. Walter SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 30,669 30,669 - - Stock Option (Right to Buy)
Matthew R. Walter SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 4,350 30,625 (0%) 0% 0 Ordinary Shares
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 21,747 21,747 - - Performance Share Units
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 61,338 61,338 - - Stock Option (Right to Buy)
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2025 8,699 39,958 (0%) 0% 0 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Gift of securities by or to the insider at price $ 0.00 per share. 03 Jun 2025 310 10,143 (0%) 0% 0 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.85 per share. 02 May 2025 34 26,054 (0%) 0% 84.9 2,885 Ordinary Shares
Lidia L. Fonseca Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 5,891 (0%) 0% 84.0 175,055 Ordinary Shares
Lidia L. Fonseca Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 5,675 (0%) 0% 84.6 18,274 Ordinary Shares
Scott C. Donnelly Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 21,630 (0%) 0% 84.6 18,274 Ordinary Shares
Scott C. Donnelly Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 21,846 (0%) 0% 84.0 175,055 Ordinary Shares
Craig Arnold Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 40,216 (0%) 0% 84.6 18,274 Ordinary Shares
Craig Arnold Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 40,432 (0%) 0% 84.0 175,055 Ordinary Shares
Kendall J. Powell Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 48,838 (0%) 0% 84.0 175,055 Ordinary Shares
Kendall J. Powell Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 48,622 (0%) 0% 84.6 18,274 Ordinary Shares
Randall J. Hogan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 47,029 (0%) 0% 84.6 18,274 Ordinary Shares
Randall J. Hogan Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 47,245 (0%) 0% 84.0 175,055 Ordinary Shares
Kevin E. Lofton Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 8,387 (0%) 0% 84.0 175,055 Ordinary Shares
Kevin E. Lofton Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 8,171 (0%) 0% 84.6 18,274 Ordinary Shares
Elizabeth G. Nabel Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 17,615 (0%) 0% 84.6 18,274 Ordinary Shares
Elizabeth G. Nabel Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 17,831 (0%) 0% 84.0 175,055 Ordinary Shares
Andrea J. Goldsmith Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 216 10,247 (0%) 0% 84.6 18,274 Ordinary Shares
Andrea J. Goldsmith Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 10,463 (0%) 0% 84.0 175,055 Ordinary Shares
Gregory P. Lewis Director Grant, award, or other acquisition of securities at price $ 84.04 per share. 28 Apr 2025 2,083 3,966 (0%) 0% 84.0 175,055 Ordinary Shares
Gregory P. Lewis Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.60 per share. 28 Apr 2025 181 3,785 (0%) 0% 84.6 15,313 Ordinary Shares
Denise L. Blomquist Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 2,975 10,453 (0%) 0% 0 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.30 per share. 03 Mar 2025 575 40,675 (0%) 0% 94.3 54,223 Ordinary Shares
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 29,574 29,574 - - Stock Option (Right to Buy)
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 10,605 10,605 - - Performance Share Unit
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 94.30 per share. 03 Mar 2025 26,512 30,754 (0%) 0% 94.3 2,500,082 Ordinary Shares
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 94.30 per share. 03 Mar 2025 4,242 4,242 (0%) 0% 94.3 400,021 Ordinary Shares
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 29,574 29,574 - - Stock Option (Right to Buy)
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 26,512 30,754 (0%) 0% 0 Ordinary Shares
Thierry Pieton EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 4,242 4,242 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 34,741 0 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.46 per share. 27 Jan 2025 30,184 186,770 (0%) 0% 92.5 2,790,813 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. 27 Jan 2025 34,741 216,954 (0%) 0% 74.8 2,600,016 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 2,345 0 - - Stock Option (Right to Buy)
Michael Marinaro EVP & President, Surgical OU Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. 27 Jan 2025 2,345 43,323 (0%) 0% 74.8 175,500 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.46 per share. 27 Jan 2025 2,073 41,250 (0%) 0% 92.5 191,670 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 1,337 0 - - Stock Option (Right to Buy)
Matthew R. Walter SVP, Chief HR Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. 27 Jan 2025 1,337 26,997 (0%) 0% 74.8 100,061 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.46 per share. 27 Jan 2025 1,174 25,823 (0%) 0% 92.5 108,548 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. 24 Jan 2025 12,437 53,416 (0%) 0% 78 970,086 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Sale of securities on an exchange or to another person at price $ 90.00 per share. 24 Jan 2025 12,437 40,979 (0%) 0% 90 1,119,330 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jan 2025 12,437 0 - - Stock Option (Right to Buy)
Gary Corona Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 11,315 44,255 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.48 per share. 16 Dec 2024 532 54,692 (0%) 0% 82.5 43,879 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.48 per share. 16 Dec 2024 645 43,708 (0%) 0% 82.5 53,200 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.48 per share. 16 Dec 2024 4,417 181,326 (0%) 0% 82.5 364,314 Ordinary Shares
Sean M. Salmon EVP & President Cardiovascular 16 Dec 2024 645 64,722 (0%) 0% 82.5 53,200 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. 10 Dec 2024 3,009 55,224 (0%) 0% 83.6 251,492 Ordinary Shares
Gary Corona Interim CFO 06 Dec 2024 662 32,721 (0%) 0% 84.0 55,615 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 06 Dec 2024 646 28,011 (0%) 0% 84.0 54,270 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.38 per share. 20 Aug 2024 2,045 40,346 (0%) 0% 85.4 174,602 Ordinary Shares
Gary Corona Interim CFO 15 Aug 2024 8,966 33,035 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 2,985 57,963 (0%) 0% 81.5 243,307 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 2,802 60,948 (0%) 0% 81.5 228,391 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 6,144 63,750 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 3,423 57,606 (0%) 0% 81.5 279,009 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 8,370 61,029 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 6,144 0 - - Performance Share Units
Ivan K. Fong EVP GENERAL COUNSEL & SECR Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 8,370 0 - - Performance Share Units
Gregory L. Smith EVP Global Ops & Supply Chain Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 3,490 64,757 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 1,374 63,383 (0%) 0% 81.5 111,995 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 1,513 61,870 (0%) 0% 81.5 123,325 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 3,490 0 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 2,362 46,807 (0%) 0% 81.5 192,527 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 5,311 49,169 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 5,311 0 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 2,701 44,106 (0%) 0% 81.5 220,159 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 7,132 0 - - Performance Share Units
Karen L. Parkhill EVP & Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 3,581 46,730 (0%) 0% 81.5 291,887 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 3,148 50,311 (0%) 0% 81.5 256,593 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 7,132 53,459 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 8,649 194,437 (0%) 0% 81.5 704,980 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 18,966 203,086 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 18,966 0 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 9,523 184,914 (0%) 0% 81.5 776,220 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2024 384 28,504 (0%) 0% 81.5 31,300 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2024 1,138 0 - - Performance Share Units
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2024 1,138 28,980 (0%) 0% 0 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2024 92 28,888 (0%) 0% 81.5 7,499 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 02 Aug 2024 657 67,889 (0%) 0% 81.5 53,552 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 02 Aug 2024 5,462 68,546 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 02 Aug 2024 5,462 0 - - Performance Share Units
Sean Salmon EVP & President Cardiovascular 02 Aug 2024 2,779 65,110 (0%) 0% 81.5 226,516 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 1,670 0 - - Performance Share Unit
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 847 42,391 (0%) 0% 81.5 69,039 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. 02 Aug 2024 563 43,238 (0%) 0% 81.5 45,890 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2024 1,670 43,801 (0%) 0% 0 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer 02 Aug 2024 210 25,679 (0%) 0% 81.5 17,117 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer 02 Aug 2024 684 0 - - Performance Share Unit
Matthew R. Walter SVP, Chief HR Officer 02 Aug 2024 231 25,448 (0%) 0% 81.5 18,829 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer 02 Aug 2024 684 25,889 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.32 per share. 31 Jul 2024 1,406 61,267 (0%) 0% 80.3 112,930 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 13,750 42,131 (0%) 0% 0 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jul 2024 34,375 34,375 - - Performance Share Unit
Michael Marinaro EVP & President, Surgical OU Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 101,640 101,640 - - Stock Option (Right to Buy)
Matthew R. Walter SVP, Chief HR Officer 29 Jul 2024 19,063 19,063 - - Performance Share Unit
Matthew R. Walter SVP, Chief HR Officer 29 Jul 2024 56,364 56,364 - - Stock Option (Right to Buy)
Matthew R. Walter SVP, Chief HR Officer 29 Jul 2024 7,625 25,205 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 12,750 52,659 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 94,248 92,248 - - Stock Option (Right to Buy)
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 31,875 31,875 - - Performance Share Unit
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 106,260 106,260 - - Stock Option (Right to Buy)
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 14,375 62,673 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 35,938 35,938 - - Performance Share Unit
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 106,260 106,260 - - Stock Option (Right to Buy)
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 35,938 35,938 - - Performance Share Unit
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 14,375 43,858 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 100,000 100,000 - - Performance Share Unit
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 295,680 295,680 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2024 40,000 184,120 (0%) 0% 0 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 29 Jul 2024 6,326 27,842 (0%) 0% 0 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 29 Jul 2024 1,540 1,540 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 29 Jul 2024 3,125 3,125 - - Performance Share Unit
Jennifer M. Kirk Chief Accounting Officer 29 Jul 2024 7,813 7,813 - - Performance Share Unit
Jennifer M. Kirk Chief Accounting Officer 29 Jul 2024 7,813 21,516 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 29 Jul 2024 35,938 35,938 - - Performance Share Unit
Sean Salmon EVP & President Cardiovascular 29 Jul 2024 14,375 63,084 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 29 Jul 2024 106,260 106,260 - - Stock Option (Right to Buy)
Matthew R. Walter SVP, Chief HR Officer 18 Jul 2024 492 17,580 (0%) 0% 62.8 30,878 Ordinary Shares
Matthew R. Walter SVP, Chief HR Officer 18 Jul 2024 492 0 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 83.82 per share. 07 Jun 2024 1,594 143,348 (0%) 0% 83.8 133,609 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 1,594 0 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2024 17,519 1,594 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. 07 Jun 2024 17,519 160,867 (0%) 0% 62.8 1,099,492 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Sale of securities on an exchange or to another person at price $ 83.76 per share. 07 Jun 2024 17,519 144,942 (0%) 0% 83.8 1,467,391 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. 07 Jun 2024 1,594 162,461 (0%) 0% 62.8 100,039 Ordinary Shares
Craig Arnold Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 38,275 (0%) 0% 80.9 15,531 Ordinary Shares
Denise M. O'Leary Director 01 May 2024 192 77,057 (0%) 0% 80.9 15,531 Ordinary Shares
Kendall J. Powell Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 45,843 (0%) 0% 80.9 15,531 Ordinary Shares
Lidia L. Fonseca Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 162 3,682 (0%) 0% 80.9 13,104 Ordinary Shares
Randall J. Hogan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 45,088 (0%) 0% 80.9 15,531 Ordinary Shares
Scott C. Donnelly Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 19,604 (0%) 0% 80.9 15,531 Ordinary Shares
Kevin E. Lofton Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 6,230 (0%) 0% 80.9 15,531 Ordinary Shares
Elizabeth G. Nabel Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 15,674 (0%) 0% 80.9 15,531 Ordinary Shares
Andrea J. Goldsmith Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.89 per share. 01 May 2024 192 8,306 (0%) 0% 80.9 15,531 Ordinary Shares
Craig Arnold Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 38,467 (0%) 0% 80.9 175,062 Ordinary Shares
Denise M. O'Leary Director 29 Apr 2024 2,165 77,249 (0%) 0% 80.9 175,062 Ordinary Shares
Kendall J. Powell Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 46,035 (0%) 0% 80.9 175,062 Ordinary Shares
Lidia L. Fonseca Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 3,844 (0%) 0% 80.9 175,062 Ordinary Shares
Randall J. Hogan Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 45,280 (0%) 0% 80.9 175,062 Ordinary Shares
Scott C. Donnelly Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 19,796 (0%) 0% 80.9 175,062 Ordinary Shares
Kevin E. Lofton Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 6,422 (0%) 0% 80.9 175,062 Ordinary Shares
Elizabeth G. Nabel Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 15,866 (0%) 0% 80.9 175,062 Ordinary Shares
Andrea J. Goldsmith Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 2,165 8,498 (0%) 0% 80.9 175,062 Ordinary Shares
Gregory P. Lewis Director Grant, award, or other acquisition of securities at price $ 80.86 per share. 29 Apr 2024 1,821 1,821 (0%) 0% 80.9 147,246 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Sale of securities on an exchange or to another person at price $ 83.14 per share. 08 Apr 2024 854 27,925 (0%) 0% 83.1 71,002 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.60 per share. 05 Mar 2024 563 28,779 (0%) 0% 83.6 47,067 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 21 Feb 2024 16,035 48,289 (0%) 0% 85.1 1,364,899 Ordinary Shares
Salmon Sean EVP & President Cardiovascular 21 Feb 2024 1,594 13,066 - - Stock Option (Right to Buy)
Sean Salmon EVP & President Cardiovascular 21 Feb 2024 16,035 0 - - Stock Option (Right to Buy)
Sean Salmon EVP & President Cardiovascular 21 Feb 2024 1,594 77,390 (0%) 0% 85.1 135,586 Ordinary Shares
Salmon Sean EVP & President Cardiovascular 21 Feb 2024 13,066 0 - - Stock Option (Right to Buy)
Salmon Sean EVP & President Cardiovascular 21 Feb 2024 13,066 62,949 (0%) 0% 62.8 820,022 Ordinary Shares
Salmon Sean EVP & President Cardiovascular 21 Feb 2024 13,066 64,324 (0%) 0% 85.2 1,112,570 Ordinary Shares
Salmon Sean EVP & President Cardiovascular 21 Feb 2024 1,594 49,833 (0%) 0% 62.8 100,039 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 21 Feb 2024 16,035 78,984 (0%) 0% 74.8 1,200,059 Ordinary Shares
M. Jennifer Kirk Chief Accounting Officer 01 Feb 2024 1,159 13,208 (0%) 0% 88.1 102,096 Ordinary Shares
Wall A. Brett EVP & Pres Neuroscience Sale of securities on an exchange or to another person at price $ 82.17 per share. 19 Dec 2023 4,997 28,910 (0%) 0% 82.2 410,603 Ordinary Shares
White Robert J. EVP & Pres. Medical Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.27 per share. 08 Dec 2023 369 48,410 (0%) 0% 79.3 29,251 Ordinary Shares
K. Fong Ivan EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.27 per share. 08 Dec 2023 716 40,091 (0%) 0% 79.3 56,757 Ordinary Shares
Ivan Fong K. EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.35 per share. 08 Dec 2023 1,952 39,201 (0%) 0% 79.3 154,891 Ordinary Shares
Wall Brett A. EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.27 per share. 08 Dec 2023 435 33,907 (0%) 0% 79.3 34,482 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 08 Dec 2023 435 48,103 (0%) 0% 79.3 34,482 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 30 Oct 2023 1,695 1,695 - - Stock Option (Right to Buy)
Gregory L. Smith EVP Global Ops & Supply Chain Sale of securities on an exchange or to another person at price $ 83.84 per share. 23 Aug 2023 10,000 46,723 (0%) 0% 83.8 838,400 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Sale of securities on an exchange or to another person at price $ 83.38 per share. 14 Aug 2023 1,000 33,573 (0%) 0% 83.4 83,380 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 6,217 0 - - Performance Share Units
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 6,217 61,416 (0%) 0% 0 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 4,693 56,723 (0%) 0% 84.5 396,512 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 5,168 38,857 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 5,168 0 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 4,284 34,573 (0%) 0% 84.5 361,955 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 5,919 46,327 (0%) 0% 84.5 500,096 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 7,105 52,246 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 7,105 0 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 17,965 141,144 (0%) 0% 84.5 1,517,863 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 18,165 0 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 18,165 159,109 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 4,051 52,748 (0%) 0% 84.5 342,269 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 4,251 56,799 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 4,251 0 - - Performance Share Units
Jennifer M. Kirk Chief Accounting Officer 03 Aug 2023 1,178 0 - - Performance Share Units
Jennifer M. Kirk Chief Accounting Officer 03 Aug 2023 361 14,193 (0%) 0% 84.5 30,501 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 03 Aug 2023 1,178 14,554 (0%) 0% 0 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 5,813 52,030 (0%) 0% 0 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 5,813 0 - - Performance Share Units
Robert J. White EVP & Pres. Medical Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 4,065 47,965 (0%) 0% 84.5 343,452 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 03 Aug 2023 5,604 0 - - Performance Share Units
Sean Salmon EVP & President Cardiovascular 03 Aug 2023 5,604 52,095 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 03 Aug 2023 4,369 47,726 (0%) 0% 84.5 369,137 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Aug 2023 1,696 31,605 (0%) 0% 0 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Aug 2023 1,696 0 - - Performance Share Unit
Michael Marinaro EVP & President, Surgical OU Sale of securities on an exchange or to another person at price $ 84.11 per share. 03 Aug 2023 1,352 28,930 (0%) 0% 84.1 113,717 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. 03 Aug 2023 1,323 30,282 (0%) 0% 84.5 111,780 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 7,977 40,807 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 56,162 56,162 - - Stock Option (Right to Buy)
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 19,941 19,941 - - Performance Share Units
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 64,185 64,185 - - Stock Option (Right to Buy)
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 22,790 22,790 - - Performance Share Units
Gregory L. Smith EVP Global Ops & Supply Chain Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 26,209 55,167 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 9,686 33,634 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Jul 2023 68,196 68,196 - - Stock Option (Right to Buy)
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 24,214 24,214 - - Performance Share Units
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 12,535 44,418 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 88,254 88,254 - - Stock Option (Right to Buy)
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 31,336 31,336 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 85,461 85,461 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 240,691 481,382 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 34,185 139,097 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 21,366 21,366 - - Performance Share Units
Robert Ten Hoedt EVP and Pres. Global Regions Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 8,547 52,499 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 60,173 60,173 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 31 Jul 2023 20,058 20,058 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 31 Jul 2023 2,849 13,376 (0%) 0% 0 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 31 Jul 2023 7,122 7,122 - - Performance Share Units
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 9,116 46,156 (0%) 0% 0 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 22,790 22,790 - - Performance Share Units
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 64,185 64,185 - - Stock Option (Right to Buy)
Sean Salmon EVP & President Cardiovascular 31 Jul 2023 9,686 46,290 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 31 Jul 2023 68,196 68,196 - - Stock Option (Right to Buy)
Sean Salmon EVP & President Cardiovascular 31 Jul 2023 21,214 21,214 - - Performance Share Units
Michael Marinaro EVP & President, Surgical OU Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 6,837 29,890 (0%) 0% 0 Ordinary Shares
Michael Marinaro EVP & President, Surgical OU Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 48,139 48,139 - - Stock Option (Right to Buy)
Michael Marinaro EVP & President, Surgical OU Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2023 17,093 17,093 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Sale of securities on an exchange or to another person at price $ 87.97 per share. 14 Jul 2023 2,000 23,948 (0%) 0% 88.0 175,940 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Sale of securities on an exchange or to another person at price $ 86.59 per share. 10 Jul 2023 1,808 43,802 (0%) 0% 86.6 156,555 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. 10 Jul 2023 1,808 45,610 (0%) 0% 55.3 100,019 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2023 3,706 0 - - Stock Option (Right to Buy)
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2023 1,808 3,706 - - Stock Option (Right to Buy)
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. 10 Jul 2023 3,706 47,508 (0%) 0% 55.3 205,016 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Sale of securities on an exchange or to another person at price $ 86.58 per share. 10 Jul 2023 3,706 43,802 (0%) 0% 86.6 320,865 Ordinary Shares
Craig Arnold Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 36,405 (0%) 0% 90.7 175,012 Ordinary Shares
Craig Arnold Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 36,236 (0%) 0% 90.2 15,249 Ordinary Shares
Denise M. O'Leary Director 01 May 2023 169 73,838 (0%) 0% 90.2 15,249 Ordinary Shares
Denise M. O'Leary Director 01 May 2023 1,930 74,007 (0%) 0% 90.7 175,012 Ordinary Shares
Kendall J. Powell Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 40,161 (0%) 0% 90.7 175,012 Ordinary Shares
Kendall J. Powell Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 39,992 (0%) 0% 90.2 15,249 Ordinary Shares
Lidia L. Fonseca Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,624 1,624 (0%) 0% 90.7 147,264 Ordinary Shares
Randall J. Hogan Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 6,133 (0%) 0% 90.7 175,012 Ordinary Shares
Randall J. Hogan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 5,964 (0%) 0% 90.2 15,249 Ordinary Shares
Richard H. Anderson Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 113,023 (0%) 0% 90.2 15,249 Ordinary Shares
Richard H. Anderson Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 113,192 (0%) 0% 90.7 175,012 Ordinary Shares
Scott C. Donnelly Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 16,576 (0%) 0% 90.2 15,249 Ordinary Shares
Scott C. Donnelly Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 16,745 (0%) 0% 90.7 175,012 Ordinary Shares
Kevin E. Lofton Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 4,360 (0%) 0% 90.7 175,012 Ordinary Shares
Kevin E. Lofton Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 4,191 (0%) 0% 90.2 15,249 Ordinary Shares
Elizabeth G. Nabel Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 13,804 (0%) 0% 90.7 175,012 Ordinary Shares
Elizabeth G. Nabel Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 13,635 (0%) 0% 90.2 15,249 Ordinary Shares
Andrea J. Goldsmith Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.23 per share. 01 May 2023 169 6,267 (0%) 0% 90.2 15,249 Ordinary Shares
Andrea J. Goldsmith Director Grant, award, or other acquisition of securities at price $ 90.68 per share. 01 May 2023 1,930 6,436 (0%) 0% 90.7 175,012 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.72 per share. 18 Apr 2023 74 28,882 (0%) 0% 80.7 5,973 Ordinary Shares
Gregory L. Smith EVP Global Ops & Supply Chain Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.27 per share. 05 Apr 2023 6,866 28,579 (0%) 0% 80.3 551,134 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 01 Feb 2023 672 10,115 (0%) 0% 85.8 57,637 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 13 Dec 2022 14,823 0 - - Stock Option (Right to Buy)
Sean Salmon EVP & President Cardiovascular 13 Dec 2022 14,823 52,719 (0%) 0% 55.3 820,008 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 13 Dec 2022 1,808 37,896 (0%) 0% 55.3 100,019 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 13 Dec 2022 16,631 36,088 (0%) 0% 80.5 1,338,736 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 13 Dec 2022 1,808 0 - - Stock Option (Right to Buy)
Ivan K. Fong EVP GENERAL COUNSEL & SECR Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.59 per share. 09 Dec 2022 5,206 32,830 (0%) 0% 78.6 409,140 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. 07 Dec 2022 337 25,470 (0%) 0% 79.0 26,636 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. 07 Dec 2022 348 36,186 (0%) 0% 79.0 27,506 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 07 Dec 2022 300 36,088 (0%) 0% 79.0 23,712 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Oct 2022 2,404 0 - - Stock Option (Right to Buy)
Robert Ten Hoedt EVP and Pres. Global Regions Sale of securities on an exchange or to another person at price $ 81.54 per share. 14 Oct 2022 2,404 43,483 (0%) 0% 81.5 196,015 Ordinary Shares
Robert Ten Hoedt EVP and Pres. Global Regions Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.60 per share. 14 Oct 2022 2,404 45,887 (0%) 0% 41.6 100,006 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 54,849 54,849 - - Stock Option (Right to Buy)
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 6,941 37,722 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 17,351 17,351 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 18,802 18,802 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 59,433 59,433 - - Stock Option (Right to Buy)
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 7,521 25,646 (0%) 0% 0 Ordinary Shares
Carol A. Surface EVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 12,893 12,893 - - Performance Share Units
Carol A. Surface EVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 40,754 40,754 - - Stock Option (Right to Buy)
Carol A. Surface EVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 5,157 26,193 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 10,744 30,962 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 84,905 84,905 - - Stock Option (Right to Buy)
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 26,859 26,859 - - Performance Share Units
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 224,996 224,996 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 28,471 102,497 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 71,176 71,176 - - Performance Share Units
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 7,306 43,483 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 18,264 18,264 - - Performance Share Units
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 57,735 57,735 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 01 Aug 2022 5,909 5,909 - - Performance Share Units
Jennifer M. Kirk Chief Accounting Officer 01 Aug 2022 2,364 10,630 (0%) 0% 0 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 01 Aug 2022 18,679 18,679 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 01 Aug 2022 1,416 1,416 - - Stock Option (Right to Buy)
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 67,924 67,924 - - Stock Option (Right to Buy)
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 21,487 21,487 - - Performance Share Units
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 8,595 36,351 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 01 Aug 2022 8,595 36,214 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 01 Aug 2022 67,924 67,924 - - Stock Option (Right to Buy)
Sean Salmon EVP & President Cardiovascular 01 Aug 2022 21,487 21,487 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 7,493 18,125 (0%) 0% 0 Ordinary Shares
Carol A. Surface EVP, Chief HR Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 7,920 21,036 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 15,151 20,218 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, Chairman and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 23,410 74,026 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP & President EMEA Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 9,641 36,177 (0%) 0% 0 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 12,397 27,756 (0%) 0% 0 Ordinary Shares
John R. Liddicoat EVP & President of Americas Sale or transfer of securities back to the company at price $ 0.00 per share. 29 Jul 2022 6,543 37,374 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & President Cardiovascular 29 Jul 2022 5,808 27,619 (0%) 0% 0 Ordinary Shares
Craig Arnold Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 34,681 (0%) 0% 0 Ordinary Shares
Craig Arnold Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 34,419 (0%) 0% 103.1 27,015 Ordinary Shares
Denise M. O'Leary Director 02 May 2022 1,697 71,179 (0%) 0% 0 Ordinary Shares
Denise M. O'Leary Director 02 May 2022 262 70,917 (0%) 0% 103.1 27,015 Ordinary Shares
Kendall J. Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 37,679 (0%) 0% 0 Ordinary Shares
Kendall J. Powell Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 37,417 (0%) 0% 103.1 27,015 Ordinary Shares
Randall J. Hogan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 4,409 (0%) 0% 0 Ordinary Shares
Randall J. Hogan Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 4,147 (0%) 0% 103.1 27,015 Ordinary Shares
Richard H. Anderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 110,444 (0%) 0% 0 Ordinary Shares
Richard H. Anderson Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 110,182 (0%) 0% 103.1 27,015 Ordinary Shares
Scott C. Donnelly Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 15,124 (0%) 0% 0 Ordinary Shares
Scott C. Donnelly Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 14,862 (0%) 0% 103.1 27,015 Ordinary Shares
Kevin E. Lofton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 2,535 (0%) 0% 0 Ordinary Shares
Kevin E. Lofton Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 161 2,374 (0%) 0% 103.1 16,601 Ordinary Shares
Elizabeth G. Nabel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 12,080 (0%) 0% 0 Ordinary Shares
Elizabeth G. Nabel Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 11,818 (0%) 0% 103.1 27,015 Ordinary Shares
Andrea J. Goldsmith Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.11 per share. 02 May 2022 262 4,450 (0%) 0% 103.1 27,015 Ordinary Shares
Andrea J. Goldsmith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 1,697 4,712 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Sale of securities on an exchange or to another person at price $ 110.00 per share. 18 Mar 2022 682 34,946 (0%) 0% 110 75,020 Ordinary Shares
Carol A. Surface SVP, Chief HR Officer Sale of securities on an exchange or to another person at price $ 105.30 per share. 11 Mar 2022 6,000 28,502 (0%) 0% 105.3 631,800 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 6,237 6,237 (0%) 0% 0 Ordinary Shares
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 21,238 21,238 - - Performance Share Units
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 145,852 145,852 - - Stock Option (Right to Buy)
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 15,591 15,591 - - Performance Share Units
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 50,476 50,476 - - Stock Option (Right to Buy)
Ivan K. Fong EVP GENERAL COUNSEL & SECR Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 24,134 30,371 (0%) 0% 0 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 01 Feb 2022 636 7,934 (0%) 0% 103.6 65,883 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Sale of securities on an exchange or to another person at price $ 102.04 per share. 23 Dec 2021 7,218 39,430 (0%) 0% 102.0 736,525 Ordinary Shares
Richard H. Anderson Director Purchase of securities on an exchange or from another person at price $ 103.26 per share. 16 Dec 2021 5,010 108,374 (0%) 0% 103.3 517,333 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 15 Dec 2021 89 33,083 (0%) 0% 104.9 9,340 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 06 Dec 2021 49,859 0 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 06 Dec 2021 49,859 49,859 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Sale of securities on an exchange or to another person at price $ 110.00 per share. 06 Dec 2021 682 35,446 (0%) 0% 110 75,020 Ordinary Shares
Richard E. Kuntz SVP & Chief Medical & Science Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. 05 Nov 2021 209 74,945 (0%) 0% 123.0 25,703 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. 05 Nov 2021 238 25,251 (0%) 0% 123.0 29,269 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. 05 Nov 2021 250 48,635 (0%) 0% 123.0 30,745 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. 05 Nov 2021 246 46,648 (0%) 0% 123.0 30,253 Ordinary Shares
John R. Liddicoat EVP & President of Americas Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. 05 Nov 2021 139 42,998 (0%) 0% 123.0 17,094 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 05 Nov 2021 245 33,172 (0%) 0% 123.0 30,130 Ordinary Shares
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 6,670 6,670 - - Stock Option (Right to Buy)
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 2,080 2,080 - - Performance Share Units
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2021 832 45,418 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 06 Oct 2021 37,859 37,859 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 06 Oct 2021 12,000 49,859 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 06 Oct 2021 12,000 35,974 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 06 Oct 2021 37,859 47,974 (0%) 0% 0 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Sale of securities on an exchange or to another person at price $ 126.58 per share. 30 Sep 2021 49,147 48,763 (0%) 0% 126.6 6,221,027 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2021 49,147 0 - - Stock Option (Right to Buy)
Bradley E. Lerman SVP General Counsel & Corp Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. 30 Sep 2021 49,147 97,910 (0%) 0% 78 3,833,466 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Sale of securities on an exchange or to another person at price $ 134.17 per share. 31 Aug 2021 50,775 48,763 (0%) 0% 134.2 6,812,482 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Aug 2021 50,775 0 - - Stock Option (Right to Buy)
Bradley E. Lerman SVP General Counsel & Corp Sec Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. 31 Aug 2021 50,775 99,538 (0%) 0% 74.8 3,800,001 Ordinary Shares
Geoffrey S. Martha Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. 25 Aug 2021 1,481 97,317 (0%) 0% 55.3 81,929 Ordinary Shares
Geoffrey S. Martha Director, CEO Sale of securities on an exchange or to another person at price $ 132.67 per share. 25 Aug 2021 1,481 95,836 (0%) 0% 132.7 196,484 Ordinary Shares
Geoffrey S. Martha Director, CEO Sale of securities on an exchange or to another person at price $ 132.67 per share. 25 Aug 2021 10,100 95,836 (0%) 0% 132.7 1,339,967 Ordinary Shares
Geoffrey S. Martha Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2021 1,481 0 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2021 10,100 17,519 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. 25 Aug 2021 10,100 105,936 (0%) 0% 62.8 633,876 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 21,129 33,329 (0%) 0% 134.1 2,832,976 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 4,713 0 - - Stock Option (Right to Buy)
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 2,577 0 - - Stock Option (Right to Buy)
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 21,129 0 - - Stock Option (Right to Buy)
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 7,290 33,329 (0%) 0% 134.1 977,516 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 4,713 40,619 (0%) 0% 38.2 180,037 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 2,577 35,906 (0%) 0% 38.8 100,013 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 25 Aug 2021 21,129 54,458 (0%) 0% 38.8 820,016 Ordinary Shares
Richard E. Kuntz SVP & Chief Medical & Science Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 4,905 69,886 (0%) 0% 131.3 644,076 Ordinary Shares
Richard E. Kuntz SVP & Chief Medical & Science Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 12,571 12,571 - - Performance Share Units
Richard E. Kuntz SVP & Chief Medical & Science Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Richard E. Kuntz SVP & Chief Medical & Science Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 42,961 42,961 - - Stock Option (Right to Buy)
Richard E. Kuntz SVP & Chief Medical & Science Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 5,029 74,915 (0%) 0% 0 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 1,482 20,062 (0%) 0% 131.3 194,601 Ordinary Shares
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 13,333 13,333 - - Performance Share Units
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 45,565 45,565 - - Stock Option (Right to Buy)
Brett A. Wall EVP & Pres Neuroscience Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 5,333 25,395 (0%) 0% 0 Ordinary Shares
Carol A. Surface SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 31,245 31,245 - - Stock Option (Right to Buy)
Carol A. Surface SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 3,657 34,327 (0%) 0% 0 Ordinary Shares
Carol A. Surface SVP, Chief HR Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 3,997 30,670 (0%) 0% 131.3 524,846 Ordinary Shares
Carol A. Surface SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 9,143 9,143 - - Performance Share Units
Carol A. Surface SVP, Chief HR Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 7,162 85,833 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 6,839 78,671 (0%) 0% 131.3 898,029 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 17,904 17,904 - - Performance Share Units
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Karen L. Parkhill EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 61,187 61,187 - - Stock Option (Right to Buy)
Bradley E. Lerman SVP General Counsel & Corp Sec Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 5,450 42,744 (0%) 0% 131.3 715,640 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Sale of securities on an exchange or to another person at price $ 131.52 per share. 02 Aug 2021 4,000 48,194 (0%) 0% 131.5 526,080 Ordinary Shares
Bradley E. Lerman SVP General Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 15,047 15,047 - - Performance Share Units
Bradley E. Lerman SVP General Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Bradley E. Lerman SVP General Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 51,423 51,423 - - Stock Option (Right to Buy)
Bradley E. Lerman SVP General Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 6,019 48,763 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 19,047 95,836 (0%) 0% 0 Ordinary Shares
Geoffrey S. Martha Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 5,450 76,789 (0%) 0% 131.3 715,640 Ordinary Shares
Geoffrey S. Martha Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 162,731 162,731 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 47,616 47,616 - - Performance Share Units
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 4,419 44,489 (0%) 0% 0 Ordinary Shares
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 37,754 37,754 - - Stock Option (Right to Buy)
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Robert Ten Hoedt EVP & President EMEA Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 11,047 11,047 - - Performance Share Units
Robert Ten Hoedt EVP & President EMEA Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 3,908 40,070 (0%) 0% 131.3 513,159 Ordinary Shares
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2021 9,764 9,764 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2021 2,857 2,857 - - Performance Share Units
Jennifer M. Kirk Chief Accounting Officer 02 Aug 2021 1,143 8,387 (0%) 0% 0 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 52,074 52,074 - - Stock Option (Right to Buy)
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 6,095 46,769 (0%) 0% 0 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 4,897 40,674 (0%) 0% 131.3 643,025 Ordinary Shares
Robert J. White EVP & Pres. Medical Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 15,237 15,237 - - Performance Share Units
John R. Liddicoat EVP & President of Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 8,381 8,381 - - Performance Share Units
John R. Liddicoat EVP & President of Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
John R. Liddicoat EVP & President of Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 28,641 28,641 - - Stock Option (Right to Buy)
John R. Liddicoat EVP & President of Americas Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2021 3,353 42,847 (0%) 0% 0 Ordinary Shares
John R. Liddicoat EVP & President of Americas Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. 02 Aug 2021 3,258 39,494 (0%) 0% 131.3 427,808 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 02 Aug 2021 1,085 1,085 - - Stock Option (Right to Buy)
Sean Salmon EVP & Pres Diabetes/Cardiovasc 02 Aug 2021 2,272 27,843 (0%) 0% 131.3 298,336 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 02 Aug 2021 5,486 33,329 (0%) 0% 0 Ordinary Shares
Sean Salmon EVP & Pres Diabetes/Cardiovasc 02 Aug 2021 46,867 46,867 - - Stock Option (Right to Buy)
Sean Salmon EVP & Pres Diabetes/Cardiovasc 02 Aug 2021 13,714 13,714 - - Performance Share Units
Geoffrey S. Martha Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. 28 Jun 2021 11,500 93,448 (0%) 0% 55.3 636,180 Ordinary Shares
Geoffrey S. Martha Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Jun 2021 11,500 1,481 - - Stock Option (Right to Buy)
Geoffrey S. Martha Director, CEO Sale of securities on an exchange or to another person at price $ 125.29 per share. 28 Jun 2021 11,500 81,948 (0%) 0% 125.3 1,440,835 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 22 Jun 2021 238 843 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 22 Jun 2021 238 85,747 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 22 Jun 2021 238 843 (0%) 0% 0 Ordinary Shares
Karen L. Parkhill EVP & Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 22 Jun 2021 238 843 (0%) 0% 0 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters